qanastek/EMEA-V3 huggingface dataset:
► If you have trouble with your kidneys or liver, your doctor may decide to alter your insulin dose ► If you are drinking alcohol (also beer and wine): watch for signs of a hypo and never drink alcohol on an empty stomach ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin.
Jekk għandek problemi fil- kliewi jew fil- fwied, it- tabib jista ’ jiddeċiedi li jibdillek id- doża ta ’ ► l- insulina Jekk qed tixrob l- alkoħol (inkluż il- birra u l- inbid): oqgħod attent għas- sinjali ta ’ ipo u qatt ► tixrob l- alkoħol fuq stonku vojt Jekk qed tagħmel eżerċizzju aktar mis- soltu jew jekk tixtieq tibdel id- dieta tas- soltu ► Jekk int marid: kompli ħu l- insulina tiegħek.
Your need for insulin may change ► If you have an infection, fever or an operation you may need more insulin than usual ► If you suffer from diarrhoea, vomiting or eat less than usual you may also need less insulin than usual ► If you are going abroad: travelling over time zones may affect your insulin needs and the timing of the injections.
Il- ħtieġa tiegħek għall- insulina tista ’ tinbidel ► Jekk għandek infezzjoni, deni jew operazzjoni jista ’ jkollok bżonn tieħu aktar insulina mis - ► soltu Jekk tbati minn dijarrea, rimettar jew tiekol inqas mis- soltu, jista ’ wkoll ikollok bżonn ► inqas insulina mis- soltu Jekk se ssiefer: l- ivvjaġġar minn żona ta ’ ħin għall- oħra jista ’ jaffettwalek il- ħtiġijiet għall - ► insulina u l- ħin meta tieħu l- injezzjonijiet.
Consult your doctor if you are planning such travelling.
Ħu parir mingħand it- tabib tiegħek jekk qed tippjana dan it- tip ta ’ vjaġġar.
Using other medicines Many medicines affect the way glucose works in your body and this may influence your insulin dose.
85 Meta tuża mediċini oħra Il- mod kif jaħdem glucose fil- ġisem tiegħek huwa affetwat minn ħafna mediċini, u dawn jistgħu jinfluwenzaw id- doża tiegħek ta ’ l- insulina.
Please consult your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.
Jekk jogħġbok għid lit- tabib jew lill- ispiżjar tiegħek jekk qiegħed tieħu jew ħadt dan l- aħħar xi mediċini oħra, anki dawk mingħajr riċetta.
Oral antidiabetic medicinal products, monoamine oxidase (MAO) inhibitors, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and glucocorticoids
Il- ħtieġa tiegħek għall- insulina tista ’ tinbidel jekk inti tieħu wkoll: prodotti mediċinali kontra d - dijabete li jittieħdu mill- ħalq, inibituri ta ’ monamine oxidase (MAO), beta- blokkanti, inibituri ta ’ l - enzima li tikkonverti l- anġjotensin (ACE), salicylates, sterojdi anaboliċi u glukokortikojdi (ħlief dawk ta ’ użu topiku), kontraċettivi orali, thiazides, ormoni tat- tirojde, simpatomimetiċi, danazol, octreotide u sulfonamidi.
NovoRapid can be used during pregnancy.
Tqala u Treddigħ Jekk int tqila jew qed tippjana tqala jew qed tredda ’: jekk jogħġbok ikkuntattja lit- tabib tiegħek għal parir, NovoRapid jista 'jintuża waqt it- tqala.
Your insulin dosage may need to be changed during pregnancy and after delivery.
Id- dożaġġ ta 'l- insulina tiegħek jista' jkollu bżonn li jinbidel matul it- tqala u wara l- ħlas.
Careful control of your diabetes, and prevention of hypoglycaemia, is important, also for the health of your baby.
Kontroll bl- attenzjoni tad- dijabete tiegħek, u l- prevenzjoni ta 'ipogliċemija, huma importanti wkoll għas- saħħa tat- tarbija tiegħek.
Driving and using machines If you drive or use tools or machines: your ability to concentrate or react may be reduced if you have a hypo.
Sewqan u tħaddim ta ’ magni Jekk issuq jew tuża għodda jew magni: il- kapaċità tiegħek li tikkonċentra jew li tirreaġixxi jistgħu jonqsu jekk ikollok ipo.
Please keep this possible problem in mind in all situations where you might put yourself and others at risk (e. g. driving a car or operating machinery).
Jekk jogħġbok żomm din il- possibbiltà f’ moħħok fis- sitwazzjonijiet kollha fejn tista ’ tqiegħed lilek innifsek jew lil ħaddieħor fil- periklu (eż. is- sewqan ta ’ karrozza jew it - tħaddim ta ’ magni).
Never drive or use machinery if you feel a hypo coming on.
Qatt m’ għandek issuq jew tħaddem magni jekk tħoss li ġejja xi ipo ġejja.
You should contact your doctor about the advisability of driving if you have frequent episodes of hypos or reduced or absent warning signs of hypos.
Iddiskuti mat- tabib tiegħek jekk għandekx issuq jew tħaddem magni jekk ikollok episodji frekwenti ta ’ ipos jew jekk is- sinjali ta ’ twissija tagħhom huma ridotti jew assenti għal kollox.
NovoRapid has a rapid onset of effect therefore if hypoglycaemia occurs, you may experience it earlier after an injection when compared to soluble insulin human.
NovoRapid jibda jaħdem malajr, u għalhekk jekk ikollok episodju ipogliċemiku dan jista ’ jseħħ aktar kmieni wara injezzjoni meta mqabbel ma ’ insulina umana solubbli.
There is no clinical experience with NovoRapid in children under the age of 2 years.
M’ hemmx esperjenza klinika b’ NovoRapid fit- tfal taħt is- sentejn.
NovoRapid can be used in children instead of soluble insulin human when a rapid onset of effect might be better.
NovoRapid jista ’ jintuża fit- tfal minflok insulina umana solubbli meta jista ’ jkun aħjar li l- prodott jibda jaħdem b’ mod aktar malajr.
For example, when it is difficult to dose the child in relation to meals.
Per eżempju, meta jkun diffiċli tikkalkula l- ħinijiet ta ’ l- injezzjoni fir- rigward tal- ħinijiet ta ’ l- ikel tat- tifel/ tifla.
HOW TO USE NOVORAPID
KIF GĦANDEK TUŻA NOVORAPID
Talk about your insulin needs with your doctor and diabetes nurse.
Kellem lit- tabib u lill- infermier/ a tad- dijabete tiegħek dwar il- ħtiġijiet tiegħek għall- insulina.
Follow their advice carefully.
Imxi mal- parir tagħhom bir- reqqa.
Eat a meal or snack containing carbohydrates within 10 minutes of the injection to avoid hypoglycaemia.
Kul ikla jew ikla ħafifa li jkun fiha l- karboidrati fi żmien 10 minuti mill- injezzjoni biex tevita l - ipogliċemija.
When necessary, NovoRapid may be given soon after the meal, instead of before the meal.
Meta jkun hemm bżonn, NovoRapid jista ’ jingħata dritt wara l- ikel, minflok qabel l- ikel.
It is recommended that you measure your blood glucose regularly.
Hu rakkomandat li regolarment tiċċekkja il- livell ta ’ glucose fid- demm tiegħek..
Before using NovoRapid
Qabel ma tuża NovoRapid
► Check the label to make sure it is the right type of insulin ► Remove the protective cap ► Disinfect the rubber membrane with a medicinal swab.
Iċċekkja t- tikketta biex taċċerta li hija t- tip korrett ta ’ insulina ► Neħħi l- għatu protettiv ► Iddiżinfetta l- membrana tal- gomma b’ tajjara b’ diżinfettant. ►
NovoRapid must not be used
NovoRapid m’ għandux jintuża
► If the protective cap is loose or missing.
Jekk l- għatu protettiv huwa laxk jew nieqes.
Each vial has a protective, tamper-proof plastic cap.
Kull kunjett għandu għatu protettiv tal- plastik ► magħmul apposta kontra t- tbagħbis.
If it isn’ t in perfect condition when you get the vial, return the vial to your supplier ► If it hasn’ t been stored correctly or if it has been frozen (see 6 How to store NovoRapid) ► If the insulin does not appear clear and colourless.
Jekk ma ġiex maħżun tajjeb jew jekk ġie ffriżat (ara 6 Kif taħżen NovoRapid) ►
NovoRapid is for injection under the skin (subcutaneously) or for continuous infusion in a pump system.
NovoRapid huwa għall- injezzjoni taħt il- ġilda jew għall- infużjoni kontinwa permezz ta ’ sistema ta ’ pompa.
NovoRapid may also be given intravenously by healthcare professionals under close supervision by a doctor.
NovoRapid jista ’ jingħata wkoll minn ġol- vini minn professjonisti fil- kura tas- saħħa taħt sorveljanza stretta minn tabib.
Always vary the sites you inject, to avoid lumps (see 5 Possible side effects).
Dejjem varja l- postijiet li tinjetta fihom, biex tevita l- għoqiedi( ara 5 Effetti sekondarji li jista ’ jkollu).
The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms.
L- aħjar postijiet fejn tinjetta lilek innifsek huma: il- parti ta ’ quddiem ta ’ qaddek (iż- żaqq); il - warrani; il- parti ta ’ quddiem ta ’ kuxxtejk jew il- parti ta ’ fuq ta ’ dirgħajk.
Your insulin will work more quickly if you inject around the waist.
L- insulina taħdem aktar malajr jekk tinjettaha madwar qaddek.
83 How to take this insulin
Kif tieħu din l- insulina
If you use only one type of insulin 1.
Jekk tuża tip wieħed biss ta ’ insulina 1.
Draw into the syringe the same amount of air as the dose of insulin you are going to inject.
Iġbed ġos- siringa l- istess ammont ta ’ arja daqs id- doża ta ’ l- insulina li se tinjetta.
Inject the air into the vial.
Injetta l- arja fil- kunjett.
Turn the vial and syringe upside down and draw the correct insulin dose into the syringe.
Aqleb il- kunjett u s- siringa ta ’ taħt fuq u iġbed d- doża korretta ta ’ l- insulina fis- siringa.
Pull the needle out of the vial.
Oħroġ il- labra ’ l barra mill- kunjett.
Then expel the air from the syringe and check that the dose is correct.
Imbagħad neħħi l- arja mis- siringa u ċċekkja li d- doża hija korretta.
If you have to mix two types of insulin 1.
Jekk trid tħallat żewġ tipi ta ’ insulina 1.
Just before use, roll the long-acting (cloudy) insulin between your hands until the liquid is uniformly white and cloudy.
Eżatt qabel l- użu, irrombla f’ idejk l- insulina (opaka) li taġixxi fit- tul sakemm b’ mod uniformi l - likwidu jsir abjad u opak.
Draw into the syringe the same amount of air as the dose of long-acting insulin.
Iġbed ġos- siringa l- istess ammont ta ’ arja daqs id- doża ta ’ l- insulina li taġixxi fit- tul.
Inject the air into the vial containing long-acting insulin and pull out the needle.
Injetta l - arja fil- kunjett li fih l- insulina li taġixxi fit- tul u oħroġ il- labra ’ l barra.
Draw into the syringe the same amount of air as the dose of NovoRapid.
Iġbed ġos- siringa l- istess ammont ta ’ arja daqs id- doża ta ’ NovoRapid.
Inject the air into the vial containing NovoRapid.
Injetta l- arja fil- kunjett li fih NovoRapid.
Turn the vial and syringe upside down and draw up the prescribed dose of NovoRapid.
Aqleb il- kunjett u s- siringa ta ’ taħt fuq u iġbed id- doża preskritta ta ’ NovoRapid.
Expel any air from the syringe and check that the dose is correct.
Neħħi l- arja mis- siringa u ċċekkja li d- doża hija korretta.
Push the needle into the vial of long-acting insulin, turn the vial and syringe upside down and draw out the dose you have been prescribed.
Daħħal il- labra fil- kunjett ta ’ l- insulina li taġixxi fit- tul, aqleb il- kunjett u s- siringa ta ’ taħt fuq u iġbed id- doża li ġiet preskritta lilek.
Expel any air from the syringe and check the dose.
Neħħi l- arja mis- siringa u ċċekkja d- doża.
Inject the mixture immediately.
Injetta t- taħlita minnufih.
Always mix NovoRapid and long-acting insulin in the same sequence.
Dejjem ħallat NovoRapid u l- insulina li taġixxi fit- tul fl- istess sekwenza.
• Pinch your skin between two fingers, push the needle into the skin fold and inject the insulin under the skin • Keep the needle under your skin for at least 6 seconds to make sure you have injected all the insulin.
• Oqros il- ġilda bejn żewġt iswaba ’, daħħal il- labra fil- ġilda merfugħa u injetta l- insulina taħt il - ġilda. • Żomm il- labra taħt il- ġilda għal mill- inqas 6 sekondi biex taċċerta li tkun injettajt l- insulina kollha.
For use in an infusion pump system:
Għall- użu f’ sistema ta ’ pompa għall- infużjoni:
NovoRapid should never be mixed with any other insulin when used in a pump.
NovoRapid m’ għandu qatt jitħallat ma ’ insulina oħra meta jintuża f’ pompa.
Follow the instructions and recommendations from your doctor regarding the use of NovoRapid in a pump.
Qabel l- użu ta ’ NovoRapid f’ sistema ta ’ pompa għandek tkun irċevejt istruzzjoni komprensiva fuq l- użu u tagħrif dwar kwalunkwe azzjoni li għandha tittieħed f’ każ ta ’ mard, livell għoli wisq jew baxx wisq ta ’ glucose fid- demm jew ħsara fis- sistema tal- pompa.
Before use of NovoRapid in the pump system you must have received a comprehensive instruction in the use and information about any actions to be taken in case of illness, too high or too low blood sugar or failure of the pump system. • Before inserting the needle, use soap and water to clean your hands and the skin where the needle is inserted so as to avoid any infection at the infusion site • When you fill a new reservoir, be certain not to leave large air bubbles in either the syringe or the tubing • Changing of the infusion set (tubing and needle) must be done according to the instructions in the product information supplied with the infusion set.
• Qabel iddaħħal il- labra, uża s- sapun u l- ilma biex tnaddaf idejk, kif ukoll dik il- parti tal- ġilda fejn tkun se ddaħħal il- labra sabiex tevita infezzjonijiet fil- post fejn tingħata l- infużjoni • Meta timla reċipjent ġdid, kun żgur li ma tħallix bżieżaq kbar ta ’ l- arja fis- siringa jew fit- tubi • Tibdil fis- sett ta ’ l- infużjoni (tubi u labra) għandu jsir skond l- istruzzjonijiet fit- tagħrif dwar il- prodott provdut mas- sett ta ’ l- infużjoni.
To get the benefit of insulin infusion, and to detect possible malfunction of the insulin pump, it is recommended that you measure your blood sugar level regularly.
Biex tieħu l- benefiċċji ta ’ l- infużjoni ta ’ l- insulina, u biex tiskopri l- eventwalità ta ’ ħsara fil- pompa ta ’ l- insulina, hu rakkomandat li tiċċekkja l- livell taz- zokkor fid- demm tiegħek regolarment.
What to do in case of pump system failure
87 X’ tagħmel f’ każ ta ’ ħsara fis- sistema tal- pompa
You should always have alternative insulin available for injection under the skin in case of pump system failure.
Dejjem għandu jkollok insulina alternattiva li tista ’ tingħata bħala injezzjoni taħt il- ġilda jekk għal li jista ’ jkun ikollha l- ħsara s- sistema tal- pompa.
If you get a hypo (hypoglycaemia)
Jekk ikollok ipo (ipogliċemija)
A hypo means your blood sugar level is too low.
Ipo tfisser li l- livell taz- zokkor fid- demm tiegħek huwa baxx wisq.
84 The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Is- sinjali ta ’ twissija ta ’ ipo jistgħu jiġu f’ daqqa u jistgħu jinkludu: għaraq kiesaħ; ġilda kiesħa u pallida; uġigħ ta ’ ras; taħbit mgħaġġel tal- qalb, tħossok imqalla ’; tħossok ħafna bil- ġuħ; tibdil temporanju fil- vista; ngħas, għeja u debbulizza mhux tas- soltu; nervożitá jew rogħda; tħossok ansjuż; tħossok konfuż; diffikultà fil- konċentrazzjoni.
If you get any of these signs: eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest.
Jekk ikollok xi wieħed minn dawn is- sinjali: ħu pilloli tal glucose jew xi ikla ħafifa b’ ħafna zokkor (ħelu, biskuttini, meraq tal- frott), imbagħad strieħ.
Don’ t take any insulin if you feel a hypo coming on.
Tiħux insulina: jekk tħoss ipo ġejja.
Carry glucose tablets, sweets, biscuits or fruit juice with you, just in case.
Ġorr miegħek pilloli tal glucose, ħelu, biskuttini jew meraq tal- frott, għal li jista ’ jkun.
Tell your relatives, friends and close colleagues that if you pass out (become unconscious), they must: turn you on your side and get medical help straight away.
Għid lill- qraba, ħbieb u kollegi qrib tiegħek li jekk iħossok ħażin (tintilef minn sensik) għandhom: idawruk fuq ġenbek u jġibu għajnuna medika minnufih.
They must not give you any food or drink, as it could choke you. ► If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death ► If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor.
Jekk l- ipogliċemija gravi ma tiġix ikkurata, tista ’ tikkawża ħsara lill- moħħ (temporanju jew ► permanenti) kif ukoll il- mewt Jekk ikollok ipo li ġġagħlek tintilef minn sensik, jew ħafna ipos, kellem lit- tabib tiegħek.
The amount or timing of your insulin, food or exercise may need to be adjusted.
L - ► ammont jew il- ħin ta ’ meta tieħu l- insulina, l- ikel jew l- eżerċizzju jistgħu jkollhom bżonn jiġu aġġustati.
You may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how to use it.
Meta tintilef minn sensik tista ’ tirkupra aktar malajr b’ injezzjoni ta ’ l- ormon glucagon mgħoti minn xi ħadd li jaf jużah.
If you are given glucagon you will need glucose or a sugary snack as soon as you are conscious.
Jekk tingħata glucagon, ser ikollok bżonn tieħu glucose jew xi ħaġa b’ ħafna zokkor malli tiġi f’ sensik.
If you do not respond to glucagon treatment, you will have to be treated in a hospital.
Jekk ma tirrispondix għall- kura bi glucagon, ser ikollok bżonn tiġi kkurat ġewwa sptar.
Contact your doctor or an emergency ward after an injection of glucagon: you need to find the reason for your hypo to avoid getting more.
Ikkuntattja lit- tabib tiegħek jew sala ta ’ emerġenza wara injezzjoni ta ’ glucagon: tkun teħtieġ li ssib ir- raġuni għall- ipo biex tevita li jkollok aktar.
Causes of a hypo
Kawżi ta ’ ipo
You get a hypo if your blood sugar gets too low.
Ikollok ipo jekk il- livell taz- zokkor fid- demm tiegħek jitbaxxa wisq.
This might happen: • If you take too much insulin • If you eat too little or miss a meal • If you exercise more than usual.
Dan jista ’ jiġri: • Jekk tieħu wisq insulina • Jekk tiekol ftit wisq jew taqbeż ikla • Jekk qiegħed tagħmel eżerċizzju aktar mis- soltu
If your blood sugar gets too high
Jekk il- livell taz- zokkor fid- demm tiegħek jogħla wisq
The warning signs appear gradually.
Il- livell taz- zokkor fid- demm tiegħek jista ’ jogħla wisq (din tissejjaħ ipergliċemija) Is- sinjali ta ’ twissija jidhru gradwalment.
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed, dry skin; dry mouth and a fruity (acetone) smell of the breath.
Dawn jinkludu: tgħaddi iżjed awrina, tħossok bil- għatx; titlef l- aptit; tħossok imqalla ’ (dardir jew rimettar); tħossok bi ngħas jew għajjien; ħmura u ġilda xotta; ħalq xott u riħa ta ’ frott (acetone) fil- ħalq.
If you get any of these signs: test your blood sugar level; test your urine for ketones if you can; then seek medical advice straight away.
Jekk ikollok xi wieħed minn dawn is- sinjali: ittestja l- livell taz- zokkor fid- demm tiegħek; jekk tista ’ ttestja l- awrina għal ketones; imbagħad fittex parir mediku minnufih.
These may be signs of a very serious condition called diabetic ketoacidosis.
Dawn jistgħu jkunu sinjali ta ’ kundizzjoni gravi ħafna msejħa ketoaċidożi dijabetika.
If you don’ t treat it, this could lead to diabetic coma and death.
Jekk ma tikkurahiex, din tista ’ twassal għal koma dijabetika u l- mewt.
Causes of hyperglycaemia
88 Kawżi ta ’ ipergliċemija
• Having forgotten to take your insulin • Repeatedly taking less insulin than you need • An infection or a fever • Eating more than usual • Less exercise than usual.
• Tinsa tieħu l- insulina tiegħek • Tieħu inqas insulina milli teħtieġ ripetutament • Infezzjoni jew deni • Tiekol aktar mis- soltu • Inqas eżerċizzju mis- soltu.
Like all medicines, NovoRapid can cause side effects, although not everybody gets them.
Bħal kull mediċina oħra, NovoRapid jista ’ jkollu effetti sekondarji, għalkemm ma jidhrux fuq kulħadd.
The most common side effect is low blood sugar (hypoglycaemia).
L- effett sekondarju l- aktar komuni huwa livell baxx taz- zokkor fid- demm (ipogliċemija).
See the advice in 4 What to do in an emergency.
X’ għandek tagħmel f’ każ ta ’ emerġenza.
85 Side effects reported uncommonly
Effetti sekondarji rrappurtati b’ mod mhux komuni
(less than 1 in 100)
(inqas minn 1 minn kull 100)
Vision problems.
Problemi bil- vista.
When you first start your insulin treatment, it may disturb your vision, but the reaction usually disappears.
Meta tibda l- kura tiegħek bl- insulina, din tista ’ tiddisturbalek il- vista, iżda normalment din r- reazzjoni tgħaddi waħidha
Changes of the injection site (Lipodystrophy).
Kambjament fis- sit ta ’ l- injezzjoni (Lipodistrofija).
If you inject yourself too often at the same site, fatty tissue under the skin at this site may shrink (lipoatrophy) or thicken (lipohypertrophy).
Jekk tinjetta lilek innifsek ta ’ spiss wisq fl - istess sit, it- tessut tax- xaħam taħt il- ġilda f’ dan is- sit jista ’ jinxtorob (lipoatrofija) jew jeħxien (lipoipertrofija).
Changing the site with each injection may help to prevent such skin changes.
Li tibdel is- sit ma ’ kull injezzjoni jista ’ jgħin biex jiġi evitat dan il- kambjament fil - ġilda.
Signs of allergy.
Sinjali ta ’ allerġija:
Reactions (redness, swelling, itching) at the injection site may occur (local allergic reactions).
Jistgħu jseħħu reazzjonijiet (ħmura, nefħa, ħakk), fis- sit ta ’ l- injezzjoni (reazzjonijiet allerġiċi lokali).
These usually disappear after a few weeks of taking your insulin.
Dawn normalment imorru wara ftit ġimgħat li tkun qed tieħu l- insulina tiegħek.
If they do not disappear, see your doctor.
Jekk ma jmorrux ara lit- tabib tiegħek.
Seek medical advice immediately: • If signs of allergy spread to other parts of your body, or • If you suddenly feel unwell, and you: start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy.
Fittex parir mediku minnufih: • Jekk is- sinjali ta ’ l- allerġija jinxterdu għal partijiet oħrajn tal- ġisem, jew • Jekk tħossok ma tiflaħx f’ daqqa, u: tibda tegħreq; tibda titqalla ’ (tirrimetti); ikollok diffikultà biex tieħu n- nifs; ikollok taħbit mgħaġġel tal- qalb; tħossok stordut.
You may have a very rare serious allergic reaction to NovoRapid or one of its ingredients (called a systemic allergic reaction).
Jista ’ jkollok allerġija rari ħafna u gravi għal NovoRapid jew għal xi wieħed mis- sustanzi tiegħu (imsejħa reazzjoni allerġika sistemika).
See also the warning in 2 Before you use NovoRapid.
Ara wkoll it- twissija f’ 2 Qabel ma tuża NovoRapid.
If you have diabetic retinopathy and your blood glucose levels improve very fast, the retinopathy may get worse.
Jekk għandek ir- retinopatija dijabetika u l- livelli ta ’ glucose fid- demm tiegħek jitjiebu malajr ħafna, ir- retinopatija tista ’ tmur għall- agħar.
Normally this soon disappears.
Normalment din malajr tmur.
Painful neuropathy.
Newropatija bl- uġigħ.
If your blood glucose levels improve very fast, you may get nerve related pain – this is called acute painful neuropathy and is usually transient.
Jekk il- livelli ta ’ glucose fid- demm tiegħek jitjiebu malajr ħafna, jista ’ jkollok uġigħ relatat man- nervituri – din tissejjaħ newropatija akuta bl- uġigħ u normalment hija tranżitorja.
HOW TO STORE NOVORAPID
KIF TAĦŻEN NOVORAPID
Do not use NovoRapid after the expiry date which is stated on the label and carton.
Tużax NovoRapid wara d- data ta ’ skadenza li tidher fuq it- tikketta u l- kartuna.
NovoRapid vials that are not being used are to be stored at 2°C – 8°C in the refrigerator, away from the freezer compartment.
Il- kunjetti ta ’ NovoRapid li mhux qed jintużaw għandhom jinħażnu fi friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
NovoRapid vials that are being used or about to be used are not to be kept in the refrigerator.
Il- kunjetti ta ’ NovoRapid li qed jintużaw jew li se jintużaw m’ għandhomx jinżammu fil- friġġ.
You can carry it with you and keep it at room temperature (not above 30°C) for up to 4 weeks.
Tista ’ ġġorrhom miegħek u żżomhom f’ temperatura tal- kamra (mhux aktar minn 30ºC) sa 4 ġimgħat.
Always keep the vial in the outer carton when you’ re not using it in order to protect it from light.
Dejjem żomm il- kunjett fil- kartuna ta ’ barra meta mhux qed tużah sabiex tilqa ’ mid- dawl.
NovoRapid must be protected from excessive heat and sunlight.
NovoRapid għandu jiġi protett mis- sħana eċċessiva u mid- dawl tax- xemx.
NovoRapid should not be disposed of via waste water or household waste.
NovoRapid m' għandux jintrema ma 'l- ilma tad- dranaġġ jew ma' l- iskart domestiku.
These measures will help to protect the environment.
Dawn il- miżuri jgħinu għall - protezzjoni ta ’ l - ambjent.
What NovoRapid contains
X’ fih NovoRapid
– The active substance is insulin aspart made by recombinant DNA technology – The other ingredients are glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
- Is- sustanzi l- oħra huma glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium
What NovoRapid looks like and contents of the pack
Id- Dehra ta 'NovoRapid u l- kontenuti tal- pakkett
The solution for injection comes as a clear, colourless, aqueous solution in packs of 1 or 5 vials of 10 ml or in a multipack of 5 x (1 x 10 ml) vials (not all packs may be marketed).
Is- soluzzjoni għall- injezzjoni tiġi bħala soluzzjoni akweja, ċara u bla kulur, f’ pakketti ta ’ 1 jew 5 kunjetti ta ’ 10 ml jew ġo pakkett multiplu ta ’ 5 x (1 x 10 ml) kunjetti (mhux il- pakketti kollha jistgħu jkunu fis- suq).
1 ml contains 100 U of insulin aspart.
Millilitru fih 100 U ta ’ insulina aspart.
1 vial contains 10 ml equivalent 1000 U.
Kunjett wieħed fih 10 ml li huma ekwivalenti għal 1000 U.
The marketing authorisation holder and manufacturer:
Id- Detentur ta ’ l- Awtorizzazzjoni għat- tqegħid fis- Suq u l- Manifattur:
Novo Nordisk A/ S, Novo Allé, DK-2880 Bagsværd, Denmark
Novo Nordisk A/ S, Novo Allé, DK- 2880 Bagsværd, Id- Danimarka
87 PACKAGE LEAFLET:
90 FULJETT TA ’ TAGĦRIF:
NovoRapid Penfill 100 U/ ml solution for injection in a cartridge insulin aspart
NovoRapid Penfill 100 U/ ml soluzzjoni għall- injezzjoni f’ skartoċċ insulin aspart
It comes in a 3 ml cartridge, called Penfill, which fits into a delivery system.
Jiġi f’ skartoċċ ta ’ 3 ml, bl- isem ta ’ Penfill u li joqgħod ġo apparat li jintuża biex tingħata l- insulina.
It will start to lower your blood sugar 10– 20 minutes after you take it, a maximum effect occurs between 1 and 3 hours and the effect lasts for 3– 5 hours.
Jibda jbaxxi il- livell taz- zokkor fid- demm tiegħek bejn 10 u 20 minuta wara li tieħdu, l- effett massimu jseħħ bejn siegħa u 3 sigħat u l- effett idum bejn 3 u 5 sigħat.
► If you are allergic (hypersensitive) to insulin aspart, metacresol or any of the other ingredients (see 7 Further information).
► Jekk inti allerġiku/ a (tbati minn sensittività eċċessiva) għal insulin aspart, metacresol jew xi sustanzi oħra ta ’ NovoRapid (ara 7 Aktar tagħrif).
Look out for the signs of allergy in 5 Possible side effects ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is symptoms of low blood sugar).
Jekk tħoss li ġejja xi ipo (ipo hija taqsira għal reazzjoni ipogliċemika u hija ġabra ta ’ sintomi li ► jindikaw livell baxx ta ’ zokkor fid- demm).
Using other medicines Many medicines affect the way glucose works in your body and this may influence your insulin dose.
91 Meta tuża mediċini oħra Il- mod kif jaħdem glucose fil- ġisem tiegħek huwa affetwat minn ħafna mediċini, u dawn jistgħu jinfluwenzaw id- doża tiegħek ta ’ l- insulina.
Your need for insulin may change if you also take:
Jekk jogħġbok għid lit- tabib jew lill- ispiżjar tiegħek jekk qiegħed tieħu jew ħadt dan l- aħħar xi mediċini oħra, anki dawk mingħajr riċetta.
88 Oral antidiabetic medicinal products, monoamine oxidase (MAO) inhibitors, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and glucocorticoids (except topical administration), oral contraceptives, thiazides, thyroid hormones, sympathomimetics, danazol, octreotide and sulphonamides.
Il- ħtieġa tiegħek għall- insulina tista ’ tinbidel jekk inti tieħu wkoll: prodotti mediċinali kontra d - dijabete li jittieħdu mill- ħalq, inibituri ta ’ monamine oxidase (MAO), beta- blokkanti, inibituri ta ’ l - enzima li tikkonverti l- anġjotensin (ACE), salicylates, sterojdi anaboliċi u glukokortikojdi (ħlief dawk ta ’ użu topiku), kontraċettivi orali, thiazides, ormoni tat- tirojde, simpatomimetiċi, danazol, octreotide u sulfonamidi.
Pregnancy and breast-feeding If you are planning a pregnancy or if you are pregnant or breast-feeding: please contact your doctor for advice.
Tqala u Treddigħ Jekk inti tqila jew qed tippjana tqala jew qed tredda ': jekk jogħġbok ikkuntattja lit- tabib tiegħek għal parir.
NovoRapid can be used during pregnancy.
NovoRapid jista 'jintuża waqt it- tqala.
Never drive or use machinery if you feel a hypo coming on.
Qatt m’ għandek issuq jew tħaddem magni jekk tħoss li ġejja xi ipo.
You should contact your doctor about the advisability of driving if you have frequent episodes of hypos or reduced or absent warning signs of hypos.
Iddiskuti mat - tabib tiegħek jekk għandekx issuq jew tħaddem magni jekk ikollok episodji frekwenti ta ’ ipos jew jekk is- sinjali ta ’ twissija tagħhom huma ridotti jew assenti għal kollox.
Talk about your insulin needs with your doctor and diabetes nurse.
Kellem lit- tabib jew lill- infermier/ a tad- djabete tiegħek dwar il- ħtiġijiet tiegħek għall- insulina.
It is recommended that you measure your blood glucose regularly.
Hu rakkomandat li inti tiċċekkja il- livell ta ’ glucose fid- demm regolarment.
► Check the label to make sure it is the right type of insulin ► Always check the cartridge, including the rubber plunger (stopper).
Iċċekkja t- tikketta biex taċċerta li hija t- tip korrett ta ’ insulina ► Dejjem iċċekkja l- iskartoċċ, inkluż il- planġer tal- gomma (tapp).
Don’ t use it if any damage is seen or if there is a gap between the rubber plunger and the white label band.
Tużahx jekk tara xi ħsara jew ► jekk hemm spazju bejn il- planġer tal- gomma u l- faxx abjad tat- tiketta.
Take it back to your supplier.
Ħudu lura għand il - fornitur tiegħek.
See your delivery system manual for further instructions ► Disinfect the rubber membrane with a medicinal swab ► Always use a new needle for each injection to prevent contamination.
Iddiżinfetta l- membrana tal- gomma b’ tajjara b’ diżinfettant. ► Għal kull injezzjoni dejjem uża labra ġdida sabiex tevita l- kontaminazzjoni ►
NovoRapid must not be used
92 NovoRapid m’ għandux jintuża
► If the cartridge or the device containing the cartridge is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or if it has been frozen (see 6 How to store NovoRapid) ► If the insulin does not appear clear and colourless.
Jekk l- iskartoċċ jew l- apparat li ġo fih hemm l- iskartoċċ jitwaqqa ’, tiġrilu l- ħsara jew ► jitgħaffeġ, hemm riskju ta ’ ħruġ ta ’ insulina Jekk ma ġiex maħżun tajjeb jew jekk ġie ffriżat (ara 6 Kif taħżen NovoRapid) ► Jekk l- insulina ma tidhirx ċara u bla kulur. ►
NovoRapid is for injection under the skin (subcutaneously) or for continuous infusion in a pump system.
NovoRapid huwa għall- injezzjoni taħt il- ġilda jew għall- infużjoni kontinwa f’ sistema ta ’ pompa.
89 Always vary the sites you inject, to avoid lumps (see 5 Possible side effects).
Dejjem varja l- postijiet li tinjetta fihom, biex tevita l- għoqiedi( ara 5 Effetti sekondarji li jista ’ jkollu).
NovoRapid Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine needles.
NovoRapid Penfill huwa magħmul biex jintuża ma ’ sistemi ta ’ l- għoti ta ’ l- insulina Novo Nordisk u labar NovoFine.
If you are treated with NovoRapid Penfill and another insulin Penfill cartridge, you must use two insulin delivery systems, one for each type of insulin.
Jekk barra n- NovoRapid Penfill qiegħed tingħata insulina oħra f’ skartoċċ Penfill, għandek tuża żewġ sistemi ta ’ l- għoti ta ’ l- insulina, waħda għal kull tip ta ’ insulina.
Do not refill NovoRapid Penfill.
Terġax timla NovoRapid Penfill.
As a precautionary measure, always carry a spare insulin delivery device in case your Penfill is lost or damaged.
Bħala miżura ta ’ prekawzjoni, dejjem ġorr apparat ta ’ l- għoti ta ’ l- insulina żejjed f’ każ li l- Penfill jintilef jew jiġrilu l- ħsara.
► Inject the insulin under the skin.
Injetta l- insulina taħt il- ġilda.
Use the injection technique advised by your doctor or diabetes nurse and described in your delivery system manual ► Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered ► After each injection be sure to remove and discard the needle and store NovoRapid without the needle attached.
Wara kull injezzjoni kun żgur li tneħħi u tarmi l- labra u aħżen NovoRapid mingħajr ma l- labra ► tkun imwaħħla.
Otherwise, the liquid may leak out which can cause inaccurate dosing.
Inkella, jista ’ joħroġ xi likwidu li jista ’ jkun il- kawża ta ’ teħid ta ’ doża żbaljata.
To get the benefit of insulin infusion, and to detect possible malfunction of the insulin pump, it is recommended that you measure your blood sugar level regularly.
Biex tieħu l- benefiċċji ta ’ l- infużjoni ta ’ l- insulina, u biex tiskopri l- eventwalità ta ’ ħsara fil- pompa ta ’ l- insulina, hu rakkomandat li inti tiċċekkja il- livell taz- zokkor fid- demm regolarment.
What to do in case of pump system failure
X’ tagħmel f’ każ ta ’ ħsara fis- sistema tal- pompa
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Is- sinjali ta ’ twissija ta ’ ipo jistgħu jiġu f’ daqqa u jistgħu jinkludu: għaraq kiesaħ; ġilda kiesħa u pallida; uġigħ ta ’ ras; taħbit mgħaġġel tal- qalb, tħossok imqalla ’; tħossok ħafna bil- ġuħ; tibdil temporanju fil- vista; ngħas, għeja u debbulizza mhux tas- soltu; nervożitá jew rogħda; tħossok ansjuż; tħossok konfuż; diffikultà fil- konċentrazzjoni.
90 Tell your relatives, friends and close colleagues that if you pass out (become unconscious), they must: turn you on your side and get medical help straight away.
Għid lill- qraba, ħbieb u kollegi qrib tiegħek li jekk iħossok ħażin (tintilef minn sensik) għandhom: idawruk fuq ġenbek u jġibu għajnuna medika minnufih.
Causes of hyperglycaemia
Kawżi ta ’ ipergliċemija
(Lipodystrophy).
Kambjament fis- sit ta ’ l- injezzjoni (Lipodistrofija).
NovoRapid Penfill that is not being used is to be stored at 2°C – 8°C in the refrigerator, away from the freezer compartment.
NovoRapid Penfill li mhux qed jintuża għandu jinħażen fi friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
NovoRapid Penfill that is being used or about to be used is not to be kept in the refrigerator.
95 NovoRapid Penfill li qed jintuża jew li dalwaqt se jintuża m’ għandux jinżamm fil- friġġ.
You can carry it with you and keep it at room temperature (not above 30°C) for up to 4 weeks.
Tista ’ ġġorru miegħek u żżommu f’ temperatura tal- kamra (mhux aktar minn 30ºC) sa 4 ġimgħat.
Always keep the cartridge in the outer carton when you’ re not using it in order to protect it from light.
Dejjem żomm l- iskartoċċ fil- kartuna ta ’ barra meta mhux qed tużah sabiex tilqa ’ mid- dawl.
NovoRapid should not be disposed of via waste water or household waste.
NovoRapid m' għandux jintrema ma 'ilma tad- dranaġġ jew ma' l- iskart domestiku.
– The active substance is insulin aspart made by recombinant DNA technology – The other ingredients are glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
– Is- sustanza attiva hi insulin aspart magħmula b’ teknoloġija tad- DNA rikombinanti – Is- sustanzi l- oħra huma glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid u ilma għall- injezzjonijiet.
92 What NovoRapid looks like and contents of the pack
Id- dehra ta 'NovoRapid u l- kontenuti tal- pakkett
The solution for injection comes as a clear, colourless, aqueous solution in packs of 5 or 10 cartridges of 3 ml (not all packs may be marketed).
Is- soluzzjoni għall- injezzjoni tiġi bħala soluzzjoni akweja, ċara u bla kulur, f' pakketti ta ’ 5 jew 10 skrataċ ta ’ 3 ml (mhux il- pakketti kollha jistgħu jkunu fis- suq).
1 ml contains 100 U of insulin aspart.
Millilitru fih 100 U ta ’ insulin aspart.
1 cartridge contains 3 ml equivalent to 300 U.
Skartoċċ wieħed fih 3 ml li huma ekwivalenti għal 300 U.
The marketing authorisation holder Novo Nordisk A/ S, Novo Allé, DK-2880 Bagsværd, Denmark
Novo Nordisk A/ S, Novo Allé, DK- 2880 Bagsværd, Id- Danimarka
NovoRapid NovoLet 100 U/ ml solution for injection in a pre-filled pen insulin aspart
NovoRapid NovoLet 100 U/ ml soluzzjoni għall- injezzjoni f’ pinna mimlija għal- lest insulin aspart
It may harm them, even if their symptoms are the same as yours – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Tista ’ tagħmlilhom il- ħsara, anki jekk ikollhom l- istess sintomi bħal tiegħek. – Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f' dan il- fuljett, jekk jogħġbok, għid lit- tabib, lill- infermier/ a tad- dijabete jew lill - ispiżjar tiegħek.
What NovoRapid is and what it is used for 2.
X’ inhu NovoRapid u għalxiex jintuża 2.
Before you use NovoRapid 3.
Qabel ma tuża NovoRapid 3.
How to use NovoRapid 4.
Kif għandek tuża NovoRapid 4.
How to store NovoRapid 7.
Kif taħżen NovoRapid 7.
Overleaf:
Fil- paġna ta ’ wara:
How to use your NovoLet.
Kif għandek tuża NovoLet
It comes in a 3 ml pre-filled pen, called NovoLet – see overleaf for detailed instructions.
Jiġi f’ pinna mimlija għal- lest ta ’ 3 ml, bl- isem ta ’ NovoLet – ara l- paġna ta ’ wara għal istruzzjonijiet dettalljati.
► If you are allergic (hypersensitive) to insulin aspart, metacresol or any of the other ingredients (see 7 Further information).
► Jekk inti allerġiku/ a (tbati minn sensittività eċċessiva) għal insulin aspart, metacresol jew għal sustanzi oħra ta ’ NovoRapid (ara 7 Aktar tagħrif).
► If you have trouble with your kidneys or liver, your doctor may decide to alter your insulin dose ► If you are drinking alcohol (also beer and wine): watch for signs of a hypo and never drink alcohol on an empty stomach ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin.
Jekk għandek problemi fil- kliewi jew fil- fwied, it- tabib jista ’ jiddeċiedi li jibdillek id- doża ta ’ ► l- insulina Jekk qed tixrob l- alkoħol (inkluż il- birra u l- inbid): oqgħod attent għas- sinjali ta ’ ipo u qatt ► tixrob l- alkoħol fuq stonku vojt
Your need for insulin may change ► If you have an infection, fever or an operation you may need more insulin than usual ► If you suffer from diarrhoea, vomiting or eat less than usual you may also need less insulin than usual
97 Jekk qed tagħmel eżerċizzju aktar mis- soltu jew jekk tixtieq tibdel id- dieta tas- soltu ► Jekk int marid: kompli ħu l- insulina tiegħek.
94 ► If you are going abroad: travelling over time zones may affect your insulin needs and the timing of the injections.
Il- ħtieġa tiegħek għall- insulina tista ’ tinbidel ► Jekk għandek infezzjoni, deni jew operazzjoni jista ’ jkollok bżonn tieħu aktar insulina mis - ► soltu Jekk tbati minn dijarrea, rimettar jew tiekol inqas mis- soltu, jista ’ wkoll ikollok bżonn ► inqas insulina mis- soltu Jekk se ssiefer: l- ivvjaġġar minn żona ta ’ ħin għall- oħra jista ’ jaffettwalek il- ħtiġijiet għall - ► insulina u l- ħin meta tieħu l- injezzjonijiet.
Using other medicines Many medicines affect the way glucose works in your body and this may influence your insulin dose.
Meta tuża mediċini oħra Il- mod kif jaħdem glucose fil- ġisem tiegħek huwa affetwat minn ħafna mediċini, u dawn jistgħu jinfluwenzaw id- doża tiegħek ta ’ l- insulina.
Oral antidiabetic medicinal products, monoamine oxidase (MAO) inhibitors, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and glucocorticoids (except topical administration), oral contraceptives, thiazides, thyroid hormones, sympathomimetics, danazol, octreotide and sulphonamides.
Il- ħtieġa tiegħek għall- insulina tista ’ tinbidel jekk inti tieħu wkoll: prodotti mediċinali kontra d - dijabete li jittieħdu mill- ħalq, inibituri ta ’ monamine oxidase (MAOI), beta- blokkanti, inibituri ta ’ l - enzima li tikkonverti l- anġjotensin, salicylates, sterojdi anaboliċi u glukokortikojdi (ħlief dawk ta ’ użu topiku), kontraċettivi orali, thiazides, ormoni tat- tirojde, simpatomimetiċi, danazol, octreotide u sulfonamidi.
NovoRapid has a rapid onset of effect therefore if hypoglycaemia occurs, you may experience it earlier after an injection when compared to soluble insulin human.
NovoRapid jibda jaħdem malajr, u għalhekk jekk l- ipogliċemija sseħħ, tista ’ tħossha aktar kmieni wara injezzjoni meta mqabbel ma ’ insulina umana solubbli.
It is recommended that you measure your blood glucose regularly.
Hu rakkomandat li inti tiċċekkja l- livell ta ’ glucose fid- demm regolarment.
Injecting the insulin
98 Kif tinjetta l- insulina
See overleaf for detailed instructions.
Ara fil- paġna ta ’ wara għal istruzzjonijiet dettaljati.
► Check the label to make sure it is the right type of insulin ► Always use a new needle for each injection to prevent contamination.
Iċċekkja t- tiketta biex taċċerta li hija t- tip korrett ta ’ insulina. ► Għal kull injezzjoni dejjem uża labra ġdida sabiex tevita l- kontaminazzjoni ►
► If the NovoLet is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or if it has been frozen (see 6 How to store NovoRapid) ► If the insulin does not appear clear and colourless.
NovoRapid m’ għandux jintuża Jekk n- NovoLet titwaqqa ’, jiġrilha l- ħsara jew titgħaffeġ, hemm riskju ta ’ ħruġ ta ’ insulina ► Jekk ma ġiex maħżun tajjeb jew jekk ġie ffriżat (ara 6 Kif taħżen NovoRapid) ► Jekk l- insulina ma tidhirx ċara u bla kulur. ►
NovoRapid may also be given intravenously by healthcare professionals under close supervision by a doctor.
NovoRapid jista ’ jingħata minn ġol- vini minn professjonisti fil- kura tas- saħħa taħt sorveljanza stretta minn tabib.
Always vary the sites you inject, to avoid lumps (see 5 Possible side effects).
Dejjem varja l- postijiet li tinjetta fihom, biex tevita l- għoqiedi (ara 5 Effetti sekondarji li jista ’ jkollu).
To get the benefit of insulin infusion, and to detect possible malfunction of the insulin pump, it is recommended that you measure your blood sugar level regularly.
Biex tieħu l- benefiċċji ta ’ l- infużjoni ta ’ l- insulina, u biex tiskopri l- eventwalità ta ’ ħsara fil- pompa ta ’ l- insulina, huwa rakkomandat li tkejjel il- livell taz- zokkor fid- demm regolarment.
What to do in case of pump system failure You should always have alternative insulin available for injection under the skin in case of pump system failure.
X’ tagħmel f’ każ ta ’ ħsara fis- sistema tal- pompa Dejjem għandu jkollok insulina alternattiva li tista ’ tingħata bħala injezzjoni taħt il- ġilda jekk għal li jista ’ jkun ikollha l- ħsara s- sistema tal- pompa.
Carry glucose tablets, sweets, biscuits or fruit juice with you, just in case.
99 Ġorr miegħek pilloli tal glucose, ħelu, biskuttini jew meraq tal- frott, għal li jista ’ jkun.
96 Using glucagon
Kif tuża glucagon
(Lipodystrophy).
100 Kambjament fis- sit ta ’ l- injezzjoni (Lipodistrofija).
97 Seek medical advice immediately: • If signs of allergy spread to other parts of your body, or • If you suddenly feel unwell, and you: start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy.
Fittex parir mediku minnufih: • Jekk is- sinjali ta ’ l- allerġija jinxterdu għal partijiet oħrajn tal- ġisem, jew • Jekk tħossok ma tiflaħx f’ daqqa, u: tibda tegħreq; tibda titqalla ’ (tirrimetti); ikollok diffikultà biex tieħu n- nifs; ikollok taħbit mgħaġġel tal- qalb; tħossok stordut.
NovoRapid NovoLet that is not being used is to be stored at 2°C – 8°C in the refrigerator, away from the freezer compartment.
NovoRapid NovoLet li mhux qeda tintuża għandha tinħażen fil- friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
NovoRapid NovoLet that is being used or about to be used is not to be kept in the refrigerator.
NovoRapid NovoLet li qeda tintuża jew li dalwaqt se tintuża m’ għandiex tinżamm fil- friġġ.
You can carry it with you and keep it at room temperature (not above 30°C) for up to 4 weeks.
Tista ’ ġġorrha miegħek u żżommha f’ temperatura tal- kamra (mhux aktar minn 30ºC) sa 4 ġimgħat.
Always keep the pen cap on your NovoLet when you’ re not using it in order to protect it from light.
Dejjem żomm l- għatu tal- pinna fuq n- NovoLet tiegħek meta mhux qed tużaha sabiex tilqa ’ mid- dawl.
– The active substance is insulin aspart made by recombinant DNA technology – The other ingredients are glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
101 – Is- sustanzi l- oħra huma glycerol, phenol, metacresol, zinc chloride, sodium chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid u ilma għall- injezzjonijiet.
98 What NovoRapid looks like and contents of the pack
Id- dehra ta 'NovoRapid u l- kontenuti tal- pakkett
The solution for injection comes as a clear, colourless, aqueous solution in packs of 5 or 10 pre-filled pens of 3 ml (not all packs may be marketed).
Is- soluzzjoni għall- injezzjoni tiġi bħala soluzzjoni akweja, ċara u bla kulur f' pakketti ta ’ 5 jew 10 pinen mimlijin għal- lest ta ’ 3 ml (mhux il- pakketti kollha jistgħu jkunu fis- suq).
1 pre-filled pen contains 3 ml equivalent to 300 U.
Pinna waħda mimlija għal- lest fiha 3 ml ekwivalenti għal 300 U.
Now turn for information on how to use your NovoLet.
Issa aqleb għal tagħrif dwar kif għandek tuża n- NovoLet tiegħek.
99 Please read the following instructions carefully before using your NovoRapid NovoLet.
102 Jekk jogħġbok aqra dawn l- istruzzjonijiet sew qabel ma tuża n- NovoRapid NovoLet tiegħek.
NovoRapid NovoLet is a simple, compact pre-filled pen.
NovoRapid NovoLet hija pinna mimlija għal- lest sempliċi u kompatta.
You can dial doses from 2 to 78 units in increments of 2 units.
Tista ’ ddawwar dożi minn 2 sa 78 unità f’ żidiet ta ’ 2 unitajiet.
As a precautionary measure, always carry a spare insulin delivery device in case your NovoLet is lost or damaged.
NovoRapid NovoLet hija magħmula biex tintuża mal- labar NovoFine Bħala miżura prekawzjonarja, dejjem ġorr apparat żejjed li jkun jista ’ jagħti l- insulina għal li jista ’ jkun n- NovoLet tiegħek tintilef jew jiġrilha l- ħsara.
Colour coding
103 Kif tibda
Check the label to be sure that your NovoRapid NovoLet contains the correct type of insulin.
Iċċekkja t- tikketta biex taċċerta li n- NovoRapid NovoLet tiegħek fiha t- tip korrett ta ’ insulina.
Take off the pen cap. • Disinfect the rubber membrane with a medicinal swab • Always use a new needle for each injection to prevent contamination • Remove the protective tab from a NovoFine needle • Screw the needle straight and tightly onto NovoRapid NovoLet (picture A)
Neħħi l- għatu tal- pinna. • Iddiżinfetta l- membrana tal- gomma b’ tajjara b’ diżinfettant • Għal kull injezzjoni dejjem uża labra ġdida sabiex tevita l- kontaminazzjoni • Neħħi s- siġill protettiv minn labra NovoFine • Invita l- labra dritta u b’ mod strett fuq NovoRapid NovoLet (stampa A) • Aqla ’ l- għatu l- kbir ta ’ barra tal- labra u l- għatu ta ’ ġewwa tal- labra.
Prior to each injection small amounts of air may collect in the needle and cartridge during normal use.
Qabel kull injezzjoni xi ammonti żgħar ta ’ arja jistgħu jinġabru fil- labra u fl- iskartoċċ waqt l- użu normali.
To avoid injection of air and ensure proper dosing: • Hold NovoRapid NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times.
Biex tevita l- injezzjoni ta ’ l- arja u taċċerta d- doża korretta: • Żomm NovoRapid NovoLet bil- labra tipponta ’ l fuq • B’ sebgħek tektek bil- mod l- iskartoċċ għal xi ftit drabi.